Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib

Published:2019-03-20 Issue:2 Volume:14 Page:159-168
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Su Yudong,Long Xiang,Song Yang,Chen Peng,Li Shanqing,Yang Huaxia,Wu Pancheng,Wang Yanyu,Bing Zhongxing,Cao Zhili,Cao Lei,Wu Yijun,Zhang Zhe,Liu Jing,Li Bing,Xiang Jianxing,Ma Ke,Zhang Tengfei,Zhang Lu,Mao Xinru,Liu Hao,Xing Puyuan,Liang Naixin^ORCID

Funder

Beijing Natural Science Foundation

Major projects of the Beijing Municipal Science and Technology Commission

Capital Special Project for Featured Clinical Application

The Peking Union Medical College Hospital Youth Fund

PUMC Special Youth Teacher Project

Science and Technique Foundation of Tianjin Public Health Bureau

The Clinical Trial Foundation of Tianjin Tumor Hospital

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11523-019-00631-x.pdf

Reference34 articles.

1. Li T, Kung HJ, Mack PC, Gandara DR. Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. J Clin Oncol. 2013;31(8):1039–49. https://doi.org/10.1200/JCO.2012.45.3753 .

2. Buettner R, Wolf J, Thomas RK. Lessons learned from lung cancer genomics: the emerging concept of individualized diagnostics and treatment. J Clin Oncol. 2013;31(15):1858–65. https://doi.org/10.1200/JCO.2012.45.9867 .

3. McLeer-Florin A, Duruisseaux M, Pinsolle J, Dubourd S, Mondet J, Phillips Houlbracq M, et al. ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer. Lung Cancer. 2018;116:15–24. https://doi.org/10.1016/j.lungcan.2017.12.004 .

4. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448(7153):561–6. https://doi.org/10.1038/nature05945 .

5. Horn L, Pao W. EML4-ALK: honing in on a new target in non-small-cell lung cancer. J Clin Oncol. 2009;27(26):4232–5. https://doi.org/10.1200/JCO.2009.23.6661 .

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib‐refractory ALK‐positive NSCLC from a phase II study;Cancer Communications;2024-02-29

2. Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer;Frontiers in Oncology;2023-10-20

3. Superior clinical outcomes in patients with non-small cell lung cancer harboring multiple ALK fusions treated with tyrosine kinase inhibitors;Translational Lung Cancer Research;2023-09

4. Spectrum of kinase gene rearrangements in a large series of paediatric inflammatory myofibroblastic tumours;Histopathology;2023-04-18

5. Molecular determinants of clinical outcomes for anaplastic lymphoma kinase–positive non-small cell lung cancer in Chinese patients: A retrospective study;Cancer Genetics;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3